190 related articles for article (PubMed ID: 32293702)
1. Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma.
Zgubieński K; Walczyk A; Kowalska A
Endokrynol Pol; 2020; 71(3):277-278. PubMed ID: 32293702
[TBL] [Abstract][Full Text] [Related]
2. Euthyroid Graves' orbitopathy and incidental papillary thyroid microcarcinoma.
Melcescu E; Horton WB; Pitman KT; Vijayakumar V; Koch CA
Hormones (Athens); 2013; 12(2):298-304. PubMed ID: 23933699
[TBL] [Abstract][Full Text] [Related]
3. [Graves' ophthalmopathy].
Eckstein A; Esser J
Internist (Berl); 2010 May; 51(5):584, 586-8, 590-2, passim. PubMed ID: 20383481
[TBL] [Abstract][Full Text] [Related]
4. Proceedings: Thyroid suppression.
Hill LD; Beebe HG; Hipp R; Jones HW
Arch Surg; 1974 Apr; 108(4):403-5. PubMed ID: 4815915
[No Abstract] [Full Text] [Related]
5. Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma.
Giovansili L; Cayrolle G; Belange G; Clavel G; Herdan ML
Ann Endocrinol (Paris); 2011 Feb; 72(1):42-4. PubMed ID: 21195999
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid microcarcinoma in Graves' disease presenting as a cystic neck mass.
Patil M; Kamalanathan S; Sahoo J; Vivekanandan M; Kate V; Pandit N; Badhe B
J Cancer Res Ther; 2015; 11(4):986-8. PubMed ID: 26881564
[TBL] [Abstract][Full Text] [Related]
7. Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.
Louvet C; De Bellis A; Pereira B; Bournaud C; Kelly A; Maqdasy S; Roche B; Desbiez F; Borson-Chazot F; Tauveron I; Batisse-Lignier M
Medicine (Baltimore); 2016 Nov; 95(48):e5474. PubMed ID: 27902601
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy.
Oeverhaus M; Koenen J; Bechrakis N; Stöhr M; Herrmann K; Fendler WP; Eckstein A; Weber M
J Nucl Med; 2023 Apr; 64(4):561-566. PubMed ID: 36418167
[TBL] [Abstract][Full Text] [Related]
9. Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients.
Leo M; Sabini E; Ionni I; Sframeli A; Mazzi B; Menconi F; Molinaro E; Bianchi F; Brozzi F; Santini P; Elisei R; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2018 Mar; 41(3):357-361. PubMed ID: 28856610
[TBL] [Abstract][Full Text] [Related]
10. [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer].
Bałdys-Waligórska A; Gołkowski F; Sokołowski G; Buziak-Bereza M; Skalski M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2008; 59(6):516-20. PubMed ID: 19347817
[TBL] [Abstract][Full Text] [Related]
11. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
Yunusa GH; Kotze T; Brink A
Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
[TBL] [Abstract][Full Text] [Related]
12. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
Munigoti S; Samat A; Keston Jones M
Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
[No Abstract] [Full Text] [Related]
13. Thyroid carcinoma on an ovarian teratoma: a case report and review of the literature.
Soto Moreno A; Venegas EM; Rodriguez JR; Sánchez F; Robles MJ; Martinez MA; Gonzalez D; Navarro E; Astorga R
Gynecol Endocrinol; 2002 Jun; 16(3):207-11. PubMed ID: 12192892
[No Abstract] [Full Text] [Related]
14. Use of methotrexate to treat isolated Graves ophthalmopathy developing years after thyroidectomy and iodine 131 treatment of papillary thyroid cancer.
Sanyal P; Bing-You RG; Braverman LE
Endocr Pract; 2008; 14(4):422-5. PubMed ID: 18558593
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
Joseph UA; Jhingran SG
Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study.
Lanzolla G; Menconi F; Nicolì F; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
J Endocrinol Invest; 2021 Dec; 44(12):2575-2579. PubMed ID: 33844165
[TBL] [Abstract][Full Text] [Related]
17. Natural history of graves' orbitopathy after treatment.
Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
[TBL] [Abstract][Full Text] [Related]
18. Unusual presentation of papillary thyroid carcinoma: about two cases.
Heureux F; Michel L; Trigaux JP; Delos M; Donckier J
Acta Clin Belg; 1996; 51(3):166-9. PubMed ID: 8766217
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial.
Moleti M; Violi MA; Montanini D; Trombetta C; Di Bella B; Sturniolo G; Presti S; Alibrandi A; Campennì A; Baldari S; Trimarchi F; Vermiglio F
J Clin Endocrinol Metab; 2014 May; 99(5):1783-9. PubMed ID: 24432992
[TBL] [Abstract][Full Text] [Related]
20. [Treatment for microcarcinoma of the thyroid. Clinical experience].
Conzo G; Esposito MG; Di Marzo M; Astarita G; Celsi S
Tumori; 2003; 89(4 Suppl):210-1. PubMed ID: 12903596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
